Pollogen to Launch FDA-Cleared Imogen at AAD Annual Meeting

Pollogen Ltd., will launch its Imogen system in the United States during the upcoming American Academy of Dermatology (AAD) meeting in Denver. The Imogen System is FDA cleared for dermatological procedures requiring ablation and resurfacing of the skin using the VoluDerm applicator. It is also intended for use in dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytids, according to the company. The system sets a new standard for aesthetic treatments delivering unsurpassed immediate and long-term treatment results.

The newly approved VoluDerm technology targets the mid-dermis with micro-pins and radio frequency, increasing production of hyaluronic acid, collagen regeneration and elastin growth. As a result, the company says, VoluDerm technology achieves significant and long-lasting dermal volumizing, wrinkle reduction, and skin resurfacing. TriPollar technology is a non-invasive solution that delivers immediate skin tightening and long-term skin rejuvenation results. The safety and efficacy of the technology have been validated in more than a dozen peer review papers and extensive clinical experience. The Imogen treatment is effective on all skin types and colors and is carried out in a fast 'walk-in walk-out' procedure with minimal discomfort. There is no downtime and patients can resume their daily routine immediately after treatment.

Pollgoen will be showcasing the Imogen system at Booth #2908 at the AAD Annual Meeting from March 22-24, 2014 in Denver.

Dr. Michael H. Gold, MD from Gold Skincare Center said: "With the Imogen system, I can finally achieve the results my patients and I desire. The facial dermal volumizing and wrinkle reduction results are exceptional. The skin becomes more supple and elastic and my patients look and feel years younger. Most importantly, the results are natural-looking which is what my patients want."

Mr. Amichai Bar-Nir, Pollogen's CEO commented: "The US market is the largest and most influential arena for aesthetic treatments. Pollogen is excited to launch the Imogen system in the US and is confident that American dermatologists will be impressed by its technology and performance and will provide their patients with unparalleled anti-aging results. "